Ron Lloyd

Ron Lloyd has extensive experience in the pharmaceutical and biotechnology industries, currently serving as President and CEO of Spinal Elements and previously as CEO of Aziyo Biologics, Inc. Prior roles include Executive Vice President and President of Hospital Therapies at Mallinckrodt Pharmaceuticals, President of the Immunology Division at Baxalta, and General Manager of BioScience for the US Region at Baxter Healthcare. Ron Lloyd holds an MBA in Business from Carnegie Mellon University's Tepper School of Business and a Bachelor's degree in Management Science from Westminster College in Pennsylvania.